443 related articles for article (PubMed ID: 25182804)
1. Diffusion-weighted imaging during MR-guided radiofrequency ablation of hepatic malignancies: analysis of immediate pre- and post-ablative diffusion characteristics.
Hoffmann R; Rempp H; Schraml C; Schwenzer N; Grözinger G; Blumenstock G; Rothgang E; Pereira PL; Claussen CD; Clasen S
Acta Radiol; 2015 Aug; 56(8):908-16. PubMed ID: 25182804
[TBL] [Abstract][Full Text] [Related]
2. Navigator respiratory-triggered diffusion-weighted imaging in the follow-up after hepatic radiofrequency ablation-initial results.
Schraml C; Schwenzer NF; Clasen S; Rempp HJ; Martirosian P; Claussen CD; Pereira PL
J Magn Reson Imaging; 2009 Jun; 29(6):1308-16. PubMed ID: 19418557
[TBL] [Abstract][Full Text] [Related]
3. Assessment of liver tumor response by high-field (3 T) MRI after radiofrequency ablation: short- and mid-term evolution of diffusion parameters within the ablation zone.
Lu TL; Becce F; Bize P; Denys A; Meuli R; Schmidt S
Eur J Radiol; 2012 Sep; 81(9):e944-50. PubMed ID: 22817977
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade.
Nasu K; Kuroki Y; Tsukamoto T; Nakajima H; Mori K; Minami M
AJR Am J Roentgenol; 2009 Aug; 193(2):438-44. PubMed ID: 19620441
[TBL] [Abstract][Full Text] [Related]
5. Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma.
Koda M; Tokunaga S; Miyoshi K; Kishina M; Fujise Y; Kato J; Matono T; Okamoto K; Murawaki Y; Kakite S
Eur J Radiol; 2012 Oct; 81(10):2730-6. PubMed ID: 22137612
[TBL] [Abstract][Full Text] [Related]
6. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
7. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted imaging of the liver in patients with chronic liver disease: comparison of monopolar and bipolar diffusion gradients for image quality and lesion detection.
Lewis S; Kamath A; Chatterji M; Patel A; Shyknevsky I; Dyvorne HA; Kuehn B; Taouli B
AJR Am J Roentgenol; 2015 Jan; 204(1):59-68. PubMed ID: 25539238
[TBL] [Abstract][Full Text] [Related]
9. Immediate post-doxorubicin drug-eluting beads chemoembolization Mr Apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study.
Kokabi N; Camacho JC; Xing M; Edalat F; Mittal PK; Kim HS
J Magn Reson Imaging; 2015 Oct; 42(4):981-9. PubMed ID: 25683022
[TBL] [Abstract][Full Text] [Related]
10. Liver lesion conspicuity during real-time MR-guided radiofrequency applicator placement using spoiled gradient echo and balanced steady-state free precession imaging.
Rempp H; Loh H; Hoffmann R; Rothgang E; Pan L; Claussen CD; Clasen S
J Magn Reson Imaging; 2014 Aug; 40(2):432-9. PubMed ID: 24677447
[TBL] [Abstract][Full Text] [Related]
11. One-month apparent diffusion coefficient correlates with response to radiofrequency ablation of hepatocellular carcinoma.
Barat M; Fohlen A; Cassinotto C; Jannot AS; Dautry R; Pelage JP; Boudiaf M; Pocard M; Eveno C; Taouli B; Soyer P; Dohan A
J Magn Reson Imaging; 2017 Jun; 45(6):1648-1658. PubMed ID: 27766709
[TBL] [Abstract][Full Text] [Related]
12. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted MRI Before and After Robotic Radiosurgery (Cyberknife®) in Primary and Secondary Liver Malignancies: A Pilot Study.
Schmid-Tannwald C; Strobl FF; Theisen D; Muacevic A; Stintzing S; Reiser MF; Trumm CG
Technol Cancer Res Treat; 2015 Apr; 14(2):191-9. PubMed ID: 24502549
[TBL] [Abstract][Full Text] [Related]
14. Relationship between diffusion-weighted magnetic resonance imaging and histological tumor grading of hepatocellular carcinoma.
Nakanishi M; Chuma M; Hige S; Omatsu T; Yokoo H; Nakanishi K; Kamiyama T; Kubota K; Haga H; Matsuno Y; Onodera Y; Kato M; Asaka M
Ann Surg Oncol; 2012 Apr; 19(4):1302-9. PubMed ID: 21927976
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation of the liver: determination of ablative margin at MR imaging with impaired clearance of ferucarbotran--feasibility study.
Mori K; Fukuda K; Asaoka H; Ueda T; Kunimatsu A; Okamoto Y; Nasu K; Fukunaga K; Morishita Y; Minami M
Radiology; 2009 May; 251(2):557-65. PubMed ID: 19251941
[TBL] [Abstract][Full Text] [Related]
16. The usefulness of diffusion-weighted imaging in the characterization of liver lesions in patients with cirrhosis.
Sandrasegaran K; Tahir B; Patel A; Ramaswamy R; Bertrand K; Akisik FM; Saxena R
Clin Radiol; 2013 Jul; 68(7):708-15. PubMed ID: 23510619
[TBL] [Abstract][Full Text] [Related]
17. Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging.
Rhee TK; Naik NK; Deng J; Atassi B; Mulcahy MF; Kulik LM; Ryu RK; Miller FH; Larson AC; Salem R; Omary RA
J Vasc Interv Radiol; 2008 Aug; 19(8):1180-6. PubMed ID: 18656011
[TBL] [Abstract][Full Text] [Related]
18. Can preoperative diffusion-weighted MRI predict postoperative hepatic insufficiency after curative resection of HBV-related hepatocellular carcinoma? A pilot study.
Kim SU; Kim YC; Choi JS; Kim KS; Choi GH; Choi JS; Park JY; Kim DY; Ahn SH; Choi EH; Park YN; Chon CY; Han KH; Kim MJ
Magn Reson Imaging; 2010 Jul; 28(6):802-11. PubMed ID: 20395100
[TBL] [Abstract][Full Text] [Related]
19. Diffusion kurtosis imaging to assess response to treatment in hypervascular hepatocellular carcinoma.
Goshima S; Kanematsu M; Noda Y; Kondo H; Watanabe H; Bae KT
AJR Am J Roentgenol; 2015 May; 204(5):W543-9. PubMed ID: 25905960
[TBL] [Abstract][Full Text] [Related]
20. Added value of diffusion-weighted MRI for evaluating viable tumor of hepatocellular carcinomas treated with radiotherapy in patients with chronic liver disease.
Park HJ; Kim SH; Jang KM; Lim S; Kang TW; Park HC; Choi D
AJR Am J Roentgenol; 2014 Jan; 202(1):92-101. PubMed ID: 24370133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
